Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0058 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

biostem us corp (HAIR) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/30/14 - $0.02
52 Week Low
12/29/14 - $0.0035
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIOSTEM US CORP (HAIR)

Related News

No related news articles were found.

biostem us corp (HAIR) Related Businessweek News

No Related Businessweek News Found

biostem us corp (HAIR) Details

Biostem U.S. Corporation, a development stage company, focuses on the development, marketing, and licensing of regenerative medical procedures and products for human hair regeneration and other medical treatments. Its principal treatment technology utilizes a patient’s own stem cells that are extracted from the patient’s blood to assist in the regeneration of hair on the patient’s scalp. The company is based in Clearwater, Florida.

biostem us corp (HAIR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

biostem us corp (HAIR) Key Developments

Biostem U.S. Corporation Suspends Operations

Biostem U.S. Corporation announced that it has suspended all operations, terminated its last full time employee, ceased recruiting medical affiliates, shut down its website and ceased all marketing efforts as a result of its financial condition.

Biostem U.S. Corporation Announces Appointment of Aurelio Valdes as New Medical Director

Biostem U.S. Corporation enters into an agreement with Aurelio Valdes, M.D. to head up their medical department and train physicians on The Biostem Method(TM) of stem cell hair re-growth treatments. Dr. Valdes will use his Florida office as the national training center for future Biostem U.S. affiliates.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HAIR:US $0.01 USD 0.00

HAIR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HAIR.
View Industry Companies

Industry Analysis


Industry Average

Valuation HAIR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOSTEM US CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at